Oslo Universitetssykehus HF
45,8 mill. krDirekte tilskudd
3,6 mrd. krForskningsmidler
1,8 mill. krSkattefordeler
Pengene år for år
Per giver
Største enkeltbeløp
12.05.2021
ForskningsrådetForskning
Multimodal Approach Targeting treatment Refractory cancers usIng neXt generation technologies and trials
128 000 000 kr
25.09.2019
ForskningsrådetForskning
ProCardio - Precision Health Center for optimized cardiac care
96 000 000 kr
11.02.2014
ForskningsrådetForskning
C3: Centre for Connected Care - Accelerating adoption and diffusion of patient-centric innovations
91 547 075 kr
01.12.2005
80 000 000 kr
21.04.2010
77 949 066 kr
15.10.2014
77 150 000 kr
Sum per kilde
| Kilde | Oppføringer | Tilskudd | Forskning | Skatt |
|---|---|---|---|---|
| Forskningsrådet | 413 | 2,9 mrd. kr | ||
| CORDIS | 139 | 719 mill. kr | ||
| Innovasjon Norge | 5 | 30,1 mill. kr | ||
| Støtteregisteret | 6 | 15,7 mill. kr | 1,8 mill. kr |
Vi legger ikke typene sammen.
Tidslinje
05.10.2026
SkatteetatenSkatt
Regionalstøtte, redusert arbeidsgiveravgift (9 registreringer, lenken viser den første)
1 825 805 kr
20.08.2026
EU, Horisont EuropaForskning
THERA-BALT: Competence Center for Theranostics and Radiopharmaceutical Excellence in the Baltic Region
11 582 946 kr
08.07.2026
3 983 223 kr
08.07.2026
7 966 446 kr
11.06.2026
ForskningsrådetForskning
DEVELOPMENT OF PHARMACOLOGICAL THERAPY AGAINST CARDIOVASCULAR CALCIFICATION
500 000 kr
03.06.2026
EU, Horisont EuropaForskning
PALACROS: Prioritising multimodal surgical care for patients with locally advanced pancreatic cancer across Europe
3 623 215 kr
19.05.2026
EU, Horisont EuropaForskning
NutriCa65: PERSONALISED NUTRITIONAL CARE FOR OLDER PATIENTS WITH LEUKAEMIA OR PANCREATIC CANCER – A PRAGMATIC IMPLEMENTATION TRIAL TO IMPROVE QUALITY OF LIFE
4 470 361 kr
13.05.2026
EU, Horisont EuropaForskning
ENACT-65: ENabling ACTion on Integrated Nutritional and Exercise Care in Cancer – for Patients 65 and Beyond
19 653 055 kr
12.05.2026
ForskningsrådetForskning
Atlas for Single-Cell Exploration of Novel Therapeutics in PSC
3 514 000 kr
06.05.2026
99 000 kr
03.04.2026
ForskningsrådetForskning
A new antibody format for potent activation of the immune system for eradication of cancer cells
500 000 kr
29.03.2026
ForskningsrådetForskning
Support for the symposium "Breaking the T cell – cancer recognition code" on the topic of development of AI-guided Cancer Immunotherapies.
150 000 kr
26.03.2026
ForskningsrådetForskning
A Novel Antifungal Candidate to Overcome Drug-Resistant Candida Infections
500 000 kr
04.02.2026
EnovaTilskudd
Investeringsstøtte til energieffektiviseringstiltak for annet enn i bygninger
2 034 000 kr
04.02.2026
EnovaTilskudd
Investeringsstøtte til energieffektiviseringstiltak for annet enn i bygninger
603 000 kr
26.11.2025
ForskningsrådetForskning
Strategies for antiplatelet management following acute coronary syndrome (STREAMLINE)
3 534 000 kr
07.11.2025
500 000 kr
30.10.2025
ForskningsrådetForskning
SyncMe: Understanding cardiac function through myocardial dyssynchrony
12 000 000 kr
09.10.2025
ForskningsrådetForskning
Common disease mechanisms in autoimmune diseases – A possible role of viruses
11 268 000 kr
29.09.2025
EU, Horisont EuropaForskning
TEARF: The Effect of Alpha emitters and Radiofrequency Fields on cancer cells in culture.
CORDIS. Beløp mangler
Ukjent beløp
24.09.2025
25 000 000 kr
28.08.2025
ForskningsrådetForskning
How can we aid transition to reusables in the Norwegian hospital sector?
150 000 kr
19.08.2025
ForskningsrådetForskning
Understanding and preventing violence in high risk individuals– a mixed-methods approach (PreVio)
76 000 kr
13.08.2025
67 697 kr
11.08.2025
ForskningsrådetForskning
ECHO: Epigenetic Cellular Hack for Oncotherapy - Engineering CAR-NK Cells to Reprogram Tumor Macrophages via Targeted dCas9 Exosomes
2 000 000 kr
08.07.2025
ForskningsrådetForskningUsikker kobling
Human avatar on chip for advancing personalized cancer therapies by integrating vascular and immune components in a Tumor-on-Chip model
3 503 000 kr
02.07.2025
ForskningsrådetForskning
SCOPE—Semantic Feature-based Communication and Control for Wireless Body Sensor-Actuator Networks
12 000 000 kr
02.07.2025
ForskningsrådetForskning
SYNAPSE: SYnergetic Network-AI Platform for Semantic Efficiency
12 000 000 kr
01.07.2025
12 000 000 kr
03.06.2025
1 750 000 kr
14.05.2025
EU, Horisont EuropaForskning
PREDI-LYNCH: Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome
26 990 448 kr
14.05.2025
EU, Horisont EuropaForskning
PanCare4AYA: Patient-centred, evidence-based late effect screening and follow-up care of survivors of adolescent and young adult cancer
2 372 834 kr
08.05.2025
ForskningsrådetForskning
A phase I/II study to investigate if gene therapy can prevent the development of severe osteoarthritis
11 960 000 kr
02.05.2025
ForskningsrådetForskning
Development of an inhaled tankyrase inhibitor for idiopathic pulmonary fibrosis therapy
5 000 000 kr
11.04.2025
ForskningsrådetForskning
Discovering vulnerabilities in colorectal cancer by measuring double stranded RNA
9 994 000 kr
02.04.2025
EU, Horisont EuropaForskning
FatVersusBile: Fatty liver versus autoimmunity of the bile ducts - defining the gut signals driving steatosis and inflammatory disease of the gut-liver axis
5 991 494 kr
28.03.2025
1 757 655 kr
11.03.2025
ForskningsrådetForskning
Deciphering integrin-specific autoantibodies in ulcerative colitis
12 000 000 kr
10.03.2025
500 000 kr
04.03.2025
ForskningsrådetForskning
mRNA-LNP vaccines delivering personalized cancer antigen to antigen presenting cells
12 000 000 kr
26.02.2025
ForskningsrådetForskning
Combating colorectal peritoneal metastases by a sustained release triple radio-immunotherapy
3 742 000 kr
25.02.2025
EnovaTilskudd
Investeringsstøtte til energieffektiviseringstiltak for annet enn i bygninger
4 005 124 kr
25.02.2025
EnovaTilskudd
Investeringsstøtte til energieffektiviseringstiltak for annet enn i bygninger
7 011 438 kr
06.02.2025
ForskningsrådetForskningUsikker kobling
Disease caused by monoclonal IgM: Cold Agglutinin Disease, Anti-MAG Polyneuropathy and Cryoglobulinaemia type II
9 756 000 kr
31.12.2024
ForskningsrådetForskning
END-TO-END PATHOLOGY: Enhancing automatic pathology with deep-learning and ground-breaking, high-throughput computational imaging systems
9 974 000 kr
19.12.2024
ForskningsrådetForskning
Interrogation of the immune-microenvironment of T-cell malignancies
3 443 000 kr
17.12.2024
ForskningsrådetForskning
Chronic lymphocytic leukemia: Improving survival and quality of life
4 590 000 kr
11.12.2024
911 008 kr
11.12.2024
EU, Horisont EuropaForskning
SCALPEL: Specific Conjugation of Antibodies to Lipid Photo-peroxidised cancer tissues for their immunogenic ELimination
21 020 739 kr
06.12.2024
ForskningsrådetForskning
Actuating nanostructured polymer microcarriers for pluripotent stem-cell derived cardiomyocyte expansion and maturation
2 165 000 kr
06.12.2024
EU, Horisont EuropaForskning
PROACT EU-Response: A European Proactive Adaptive Clinical Trials Network within EU-Response
11 121 799 kr
06.12.2024
EU, Horisont EuropaForskning
ECOPOP: EARLY COLORECTAL CANCER: PATIENT-TARGETED AND ORGAN PRESERVING TREATMENT ECOPOP
8 008 509 kr
06.12.2024
EU, Horisont EuropaForskning
AMAZING-6G: Amazing Large-Scale Trials and Pilots for Verticals in 6G
5 651 014 kr
29.11.2024
EU, Horisont EuropaForskning
FluiDx-AD: A novel test trio to detect peptide biomarkers in saliva and blood for enhanced diagnosis and management of Alzheimer's Disease
13 466 214 kr
13.11.2024
3 093 000 kr
29.10.2024
EU, Horisont EuropaForskning
OPTIPATH: ADAPTIVE OPTICAL METASURFACES FOR REAL-TIME, LABEL-FREE AND NON-DESTRUCTIVE 7D DIGITAL PATHOLOGY
783 642 kr
28.10.2024
500 000 kr
16.10.2024
14 186 000 kr
16.10.2024
250 000 kr
14.10.2024
ForskningsrådetForskning
Tegn til Bedring - mer kostnadseffektive videokonsultasjoner i psykisk helse
210 000 kr
02.10.2024
ForskningsrådetForskning
Exploring novel therapies for celiac disease centered around the autoantigen transglutaminase 2
11 999 000 kr
27.09.2024
EnovaTilskudd
Investeringsstøtte til energieffektiviseringstiltak for annet enn i bygninger
2 029 827 kr
25.09.2024
ForskningsrådetForskning
Detection, Classification, Characterization and Treatment Monitoring of Tumors by Accessible Epigenetic Classification (DC2M-TAEC)
3 435 000 kr
16.07.2024
EU, Horisont EuropaForskning
T-RAFIC: Training network for tracking and controlling therapeutic immune cells in cancer
3 462 104 kr
11.07.2024
3 462 104 kr
25.06.2024
EU, Horisont EuropaForskning
IQ-BRAIN: Improving QMRI By Realizing trustworthy integration of AI in Neuro-imaging
3 462 104 kr
14.06.2024
11 997 000 kr
30.04.2024
ForskningsrådetForskning
Læring og mestring 2024: Sammen fremmer vi helse og livskvalitet
150 000 kr
13.12.2023
EU, Horisont EuropaForskning
e-QuoL: e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families - a PanEuropean project supported by PanCare and Harmonic consortia
962 799 kr
07.12.2023
EU, Horisont EuropaForskning
ENT1DEP: ENTEROVIRUS-LINKED TYPE 1 DIABETES EXPOSED -MECHANISMS AND PREVENTION
7 286 800 kr
07.12.2023
EU, Horisont EuropaForskning
GLIOMATCH: The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics
12 209 535 kr
07.12.2023
EU, Horisont EuropaForskning
HoloSurge: Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers
10 716 392 kr
16.11.2023
EU, Horisont EuropaForskning
NuCapCure: Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.
11 520 088 kr
15.11.2023
2 000 000 kr
15.11.2023
ForskningsrådetForskning
ATMP Norway. A multi-nodal infrastructure for Advanced Therapy Medicinal Products in Norway.
50 000 000 kr
10.11.2023
EU, Horisont EuropaForskning
EBV-MS: Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis
8 766 087 kr
17.10.2023
EU, Horisont EuropaForskning
DSTrain: DSTrain - Data Science Postdoctoral Training Programme
CORDIS. Beløp mangler
Ukjent beløp
14.09.2023
3 120 000 kr
23.08.2023
228 412 kr
18.08.2023
EU, Horisont EuropaForskning
REFINE: From solar energy to fuel: A holistic artificial photosynthesis platform for the production of viable solar fuels
5 998 099 kr
12.06.2023
ForskningsrådetForskning
Personalized Rapid Ex vivo Determination of Immunotherapeutic Cancer Treatment (PREDICT)
500 000 kr
02.05.2023
ForskningsrådetForskning
Novel drugs for photomedical treatment of pigmented and other difficult-to-treat cancers
497 930 kr
25.04.2023
EU, Horisont EuropaForskning
PROMINENT: PRECISION MEDICINE PLATFORM IN NEURODEGENERATIVE DISEASE
1 798 745 kr
24.04.2023
EU, Horisont EuropaForskning
Recon4IMD: Reconstruction and Computational Modelling for Inherited Metabolic Diseases
857 687 kr
24.04.2023
EU, Horisont EuropaForskning
PRIME-ROSE: PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials
20 596 767 kr
24.04.2023
3 053 769 kr
24.04.2023
EU, Horisont EuropaForskning
ECHoS: Establishing of Cancer Mission Hubs: Networks and Synergies
CORDIS. Beløp mangler
Ukjent beløp
24.04.2023
EU, Horisont EuropaForskning
IntReALL 2020: International Study for Treatment of Childhood Relapsed ALL 2020
1 270 542 kr
14.04.2023
EU, Horisont EuropaForskning
MPX-RESPONSE: A clinical research network to improve the management of Monkeypox virus disease
8 312 790 kr
20.03.2023
ForskningsrådetForskning
Improving personalised glioblastoma care by intertwined immunomics and artificial intelligence approaches
4 049 000 kr
15.03.2023
ForskningsrådetForskning
LysoDARE - Mechanisms and therapeutic application of lysosome repair
8 000 000 kr
15.03.2023
5 385 000 kr
08.02.2023
ForskningsrådetForskning
Moving towards evidence-based treatment strategies for children with juvenile idiopathic arthritis in sustained remission: The MOVE-JIAtrial
10 992 000 kr
01.02.2023
10 000 000 kr
02.12.2022
EU, Horisont EuropaForskning
EUonQoL: Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe
7 571 685 kr
25.11.2022
EU, Horisont EuropaForskning
SQUEEZE: Maximising Impact of Prescription Drugs in Rheumatoid Arthritis
8 505 042 kr
08.11.2022
ForskningsrådetForskning
Artificial Intelligence powered Virtual Reality Therapy in Psychosis Treatment
250 000 kr
14.10.2022
5 000 000 kr
05.10.2022
ForskningsrådetForskning
INTRAPERITONEAL IMMUNE MODULATION FOR COLORECTAL PERITONEAL METASTASES
3 057 000 kr
21.09.2022
ForskningsrådetForskning
Understanding and preventing violence in high risk individuals– a mixed-methods approach (PreVio)
9 996 000 kr
20.09.2022
631 000 kr
20.09.2022
ForskningsrådetForskning
OpenLiverLab - Open source library for the liver, from images to clinicians
100 000 kr
16.09.2022
15 090 010 kr
06.09.2022
EU, Horisont EuropaForskning
FINALphagy: Final act of the autophagy symphony: Whole-organism orchestration of autophagy termination
5 103 581 kr
10.08.2022
ForskningsrådetForskning
E!1530. Novel Synthetic Polypeptides for Natural Killer Cell-mediated Immunotherapy for the Treatment of Multiple Myeloma.
1 897 000 kr
09.08.2022
1 900 000 kr
03.08.2022
ForskningsrådetForskning
FOODHYPERNES: Towards comprehensive analytical methods for partially hydrolysed gluten to assess product safety for celiac disease patients
2 050 000 kr
19.07.2022
EU, Horisont EuropaForskning
Melomanes: Combination therapy for the treatment of metastatic melanoma using magnetic nanoparticles
3 008 454 kr
15.07.2022
EU, Horisont EuropaForskning
DUALSAVE-FGS: Dual screening by Spectral Artificial Visual Examination (SAVE) for Female Genital Schistosomiasis (FGS) and cervical cancer. Digital, new, low-cost, and simple screening and training.
21 353 996 kr
06.07.2022
EU, Horisont EuropaForskning
GLIORESOLVE: Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment
CORDIS. Beløp mangler
Ukjent beløp
02.06.2022
499 962 kr
31.05.2022
7 950 585 kr
25.05.2022
3 075 000 kr
24.05.2022
5 000 000 kr
23.05.2022
EU, Horisont EuropaForskning
IDEA4RC: Intelligent Ecosystem to improve the governance, the sharing and the re-use of health Data for Rare Cancers
971 413 kr
23.05.2022
EU, Horisont EuropaForskning
geneTIGA: Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome editing of T cells to sustainably combat several immune diseases and cancers related to B-cell pathology
5 538 255 kr
23.05.2022
EU, Horisont EuropaForskning
GLIOBID: Guiding glioblastoma treatments by decrypting tumor biomechanics via Magnetic Resonance Elastography.
2 871 351 kr
23.05.2022
EU, Horisont EuropaForskning
environMENTAL: Reducing the impact of major environmental challenges on mental health
CORDIS. Beløp mangler
Ukjent beløp
20.05.2022
EU, Horisont EuropaForskning
MyPath: Developing and implementing innovative Patient-Centred Care Pathways for cancer patients
14 860 458 kr
19.05.2022
EU, Horisont EuropaForskning
OperA: OPTIMISING COLORECTAL CANCER PREVENTION TROUGH PERSONALISED TREATMENT WITH ARTIFICIAL INTELLIGENCE
10 104 010 kr
19.05.2022
EU, Horisont EuropaForskning
Psych-STRATA: Psych-STRATA - A Stratified Treatment Algorithm in Psychiatry: A program on stratified pharmacogenomics in severe mental illness
6 251 850 kr
18.05.2022
EU, Horisont EuropaForskning
BE-SAFE: Implementing a patient-centred and evidence-based intervention to reduce BEnzodiazepine and sedative-hypnotic use to improve patient SAFEty and quality of care
4 697 824 kr
09.02.2022
13 449 000 kr
09.02.2022
EU, Horisont EuropaForskning
ISIDORe: Integrated Services for Infectious Disease Outbreak Research
708 563 kr
02.02.2022
9 567 000 kr
02.02.2022
ForskningsrådetForskning
PrecisionCare: Improving pathways to care for children and adolescents with autism spectrum disorder
12 125 000 kr
02.02.2022
8 000 000 kr
01.02.2022
ForskningsrådetForskningUsikker kobling
Decoding the Cancer Stem Cell Niche in Triple-Negative Breast Cancer
7 816 000 kr
10.01.2022
ForskningsrådetForskningUsikker kobling
Human brain clearance imaging (HCBI): a window on physiological disturbances in the pre-diagnostic phase of neurodegenerative disease
3 000 000 kr
29.12.2021
4 996 217 kr
26.11.2021
ForskningsrådetForskning
KVAL: Design of long-acting SARS-COV-2 neutralizing antibodies
500 000 kr
15.09.2021
ForskningsrådetForskning
STIM-OA Stimuleringsmidler til Oslo universitetssykehus for publisering 2020
715 000 kr
26.05.2021
ForskningsrådetForskning
KVAL: Scalable directional pump-less perfusion (dPP) organ -on-a-chip platform
499 994 kr
12.05.2021
ForskningsrådetForskning
Multimodal Approach Targeting treatment Refractory cancers usIng neXt generation technologies and trials
128 000 000 kr
11.05.2021
ForskningsrådetForskning
Prosjektetableringsstøtte (PES) EU-søknader for helseforetak i Helse Sør-Øst
1 483 000 kr
05.05.2021
ForskningsrådetForskningUsikker kobling
Målrettet hjernetrening – et trygt system for trening av deler av hjernen hemmet i psykiske lidelser; revolusjonerende ny pasientbehandling
300 000 kr
20.04.2021
EU, Horisont 2020Forskning
SWIPT-MED: SWIPT- MED: Simultaneous Wireless Information and Power Transfer for Medical Implants
2 890 313 kr
26.03.2021
ForskningsrådetForskning
SMIT2021 - Annual conference of iSMIT (International Society for Medical Innovation and Technology)
228 648 kr
16.02.2021
15 998 000 kr
16.02.2021
22 478 771 kr
10.02.2021
ForskningsrådetForskningUsikker kobling
Long-term health effects of COVID-19 - the Norwegian Corona Cohort
7 446 000 kr
10.02.2021
ForskningsrådetForskningUsikker kobling
Exploring T cell – B cell collaboration resulting in autoimmunity
12 000 000 kr
10.02.2021
ForskningsrådetForskning
Epitranscriptomic regulation and genome stability in meiosis and the preimplantation embryo
12 000 000 kr
10.02.2021
ForskningsrådetForskningUsikker kobling
Tracking cancer growth by intelligent displacement biomaps
12 000 000 kr
09.02.2021
ForskningsrådetForskning
UNLOCKING THE POTENTIAL OF PRECISION MEDICINE TO PROMOTE DRUG SENSITIVITY IN LUNG CANCER
3 610 735 kr
05.02.2021
ForskningsrådetForskning
Trygg Natt - Sensorsystem for indirekte monitorering av pust, søvn og bevegelse for bedret pasientsikkerhet
300 000 kr
29.01.2021
EU, Horisont 2020Forskning
REALMENT: Using real-world big data from eHealth, biobanks and national registries, integrated with clinical trial data to improve outcome of severe mental disorders
5 575 622 kr
29.01.2021
1 122 451 kr
25.01.2021
EU, Horisont 2020Forskning
GERONTE: Streamlined Geriatric and Oncological evaluation based on IC Technology for holistic patient-oriented healthcare management for older multimorbid patients
921 185 kr
18.01.2021
EU, Horisont 2020Forskning
AI-Mind: Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment.
30 757 711 kr
04.12.2020
EU, Horisont 2020Forskning
PANCAIM: Pancreatic cancer AI for genomics and personalized Medicine
12 100 990 kr
01.12.2020
ForskningsrådetForskningUsikker kobling
Tailoring the targeted treatment of chronic lymphocytic leukemia
3 941 333 kr
27.11.2020
ForskningsrådetForskning
NANOPARTICLES TO OPTIMIZE THE EFFECTS OF RADIOTHERAPY OF BRAIN TUMORS: MULTI-SCALE MODELING AND EXPERIMENTAL VALIDATION (RXnanoBRAIN)
2 980 000 kr
25.11.2020
ForskningsrådetForskningUsikker kobling
ICRAD Novel Strategies to enhance vaccine immunity in neonatal livestock.
3 171 000 kr
12.11.2020
ForskningsrådetForskning
KVAL: Development of the next generation antibody therapy for the treatment of CD37+ B-cell diseases
500 000 kr
12.11.2020
EU, Horisont 2020Forskning
Gravitate-Health: Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment
1 661 709 kr
09.11.2020
EU, Horisont 2020Forskning
SISAQOL-IMI: Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials
5 654 740 kr
16.09.2020
ForskningsrådetForskning
OA-publiseringskostnader 2019 Oslo universitetssykehus - samlet søknad
942 000 kr
15.09.2020
ForskningsrådetForskningUsikker kobling
Veien til presisjonsmedisin i Norge - BigMedseminar 2020
100 000 kr
15.09.2020
7 000 000 kr
12.09.2020
500 000 kr
03.09.2020
EU, Horisont 2020Forskning
EU-RESPONSE: European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases
42 391 327 kr
31.08.2020
EU, Horisont 2020Forskning
DIRNANO: Directing the immune response through designed nanomaterials
3 134 114 kr
19.06.2020
ForskningsrådetForskning
MP: Tankyrase inhibition as a therapeutic principle in idiopathic lung fibrosis
496 415 kr
18.06.2020
ForskningsrådetForskning
E!114299 WATCH-IT: 24/7 smart monitoring of cardio-respiratory function in patients at risk of cardiovascular events
2 913 000 kr
16.06.2020
ForskningsrådetForskning
MP: Aminoacridines with dual SARS-CoV2 antiviral and immunostimulating activity
499 361 kr
04.06.2020
10 939 804 kr
03.06.2020
670 044 kr
29.05.2020
ForskningsrådetForskning
MP: Active metabolite characterization for the lead commercialization of the Oslo tankyrase inhibitor program
500 000 kr
26.05.2020
500 000 kr
25.05.2020
ForskningsrådetForskningUsikker kobling
Kinetics of Activation and Inactivation of Autophagy: Commitment, Noise Suppression and the Role of Metabolic Intermediates
12 000 000 kr
22.05.2020
ForskningsrådetForskningUsikker kobling
Cellular control of macropinososome formation and maturation
11 988 000 kr
21.05.2020
ForskningsrådetForskning
TeraEpi: Teratogenicity of anti-seizure medication: the roles of epigenetics and folic acid supplements
8 220 000 kr
20.05.2020
ForskningsrådetForskningUsikker kobling
Understanding the development of resident memory T cells (Trm) in the human small intestine using integrative multiomic approaches
3 900 000 kr
04.05.2020
ForskningsrådetForskning
Quantifying systemic immunosuppression to personalize cancer therapy
2 936 000 kr
16.04.2020
EU, Horisont 2020Forskning
INNODIA HARVEST: Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA
683 445 kr
07.04.2020
150 000 kr
30.03.2020
ForskningsrådetForskning
Defining the immune cells in COVID-19 that correlate with disease severity
3 217 000 kr
30.03.2020
ForskningsrådetForskning
Survival rates and long-term outcomes for patients with COVID-19 admitted to Norwegian ICUs
2 619 000 kr
09.03.2020
500 000 kr
25.02.2020
ForskningsrådetForskning
E!113653 Apollo: real-time AI for brain MRI radiology workflow optimization
1 984 000 kr
12.02.2020
ForskningsrådetForskning
Prosjektetableringsstøtte (PES) EU-søknader for helseforetak i Helse Sør-Øst
2 200 000 kr
30.12.2019
ForskningsrådetForskning
Analytics for computation and visualization of liver resections
15 048 000 kr
06.12.2019
EU, Horisont 2020Forskning
SMA-TB: A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients.
8 277 500 kr
27.11.2019
EU, Horisont 2020Forskning
ROVER: RELIABLE TECHNOLOGIES AND MODELS FOR VERIFIED WIRELESS BODY-CENTRIC TRANSMISSION AND LOCALIZATION
328 588 kr
22.11.2019
EU, Horisont 2020Forskning
RESCUER: RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER.
9 218 432 kr
22.11.2019
EU, Horisont 2020Forskning
PainFACT: Molecular Mechanisms Associating Chronic Pain with Fatigue, Affective Disorders, Cardiovascular Disease and Total Comorbidity
7 958 518 kr
21.11.2019
EU, Horisont 2020Forskning
CoMorMent: Predicting comorbid cardiovascular disease in individuals with mental disorder by decoding disease mechanisms
3 613 478 kr
05.11.2019
ForskningsrådetForskning
Development of CXCR4 targeting -nanosystem-imaging probes for molecular imaging of cancer cells and tumor microenvironment.
3 618 000 kr
25.09.2019
4 965 128 kr
25.09.2019
ForskningsrådetForskning
ProCardio - Precision Health Center for optimized cardiac care
96 000 000 kr
Dette mangler
- Støtte under 100 000 euro, nye forskningsmidler og kontrakter under EØS-terskelen kan mangle.
- Forskningsmidler står på prosjektansvarlig, selv om deler går videre til partnere.
- 110 oppføringer er koblet på navn fordi kilden mangler org.nr. Disse kan være feil.